Hudson Bay Capital Management LP Neogenomics Inc Transaction History

Hudson Bay Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$36.08 - $56.47 $2.71 Million - $4.24 Million	-75,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$24.21 - $31.02 $1.82 Million - $2.33 Million	75,000 New	75,000 $2.32 Million
Q4 2018 Feb 13, 2019	SELL	$11.24 - $18.5 $281,000 - $462,500	-25,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $312,500 - $384,500	-25,000 Reduced 50.0%	25,000 $384,000
Q2 2018 Aug 13, 2018	SELL	$7.99 - $14.05 $619,225 - $1.09 Million	-77,500 Reduced 60.78%	50,000 $656,000
Q1 2018 May 14, 2018	SELL	$7.23 - $8.76 $162,675 - $197,100	-22,500 Reduced 15.0%	127,500 $1.04 Million
Q4 2017 Feb 12, 2018	SELL	$8.02 - $11.18 $120,300 - $167,700	-15,000 Reduced 9.09%	150,000 $1.33 Million
Q3 2017 Nov 13, 2017	BUY	$9.11 - $11.26 $1.5 Million - $1.86 Million	165,000	165,000 $1.84 Million

292

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.34B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.